ELOX
UBS Group’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-291
| Closed | -$1.4K | – | 9213 |
|
|
2023
Q3 | $1.4K | Buy |
+291
| New | +$1.4K | ﹤0.01% | 6806 |
|
|
2023
Q2 | – | Sell |
-469
| Closed | -$1.18K | – | 9128 |
|
|
2023
Q1 | $1.18K | Buy |
469
+346
| +281% | +$868 | ﹤0.01% | 7690 |
|
|
2022
Q4 | $224 | Buy |
+123
| New | +$224 | ﹤0.01% | 9098 |
|
|
2022
Q2 | – | Sell |
-21,849
| Closed | -$12K | – | 10272 |
|
|
2022
Q1 | $12K | Buy |
+21,849
| New | +$12K | ﹤0.01% | 7207 |
|
|
2021
Q3 | – | Sell |
-11,635
| Closed | -$23K | – | 9140 |
|
|
2021
Q2 | $23K | Buy |
11,635
+6,076
| +109% | +$12K | ﹤0.01% | 6119 |
|
|
2021
Q1 | $18K | Sell |
5,559
-404
| -7% | -$1.31K | ﹤0.01% | 6470 |
|
|
2020
Q4 | $24K | Buy |
+5,963
| New | +$24K | ﹤0.01% | 5812 |
|
|
2020
Q3 | – | Sell |
-7,601
| Closed | -$23K | – | 7561 |
|
|
2020
Q2 | $23K | Sell |
7,601
-7,040
| -48% | -$21.3K | ﹤0.01% | 5634 |
|
|
2020
Q1 | $29K | Sell |
14,641
-18,307
| -56% | -$36.3K | ﹤0.01% | 5352 |
|
|
2019
Q4 | $243K | Buy |
32,948
+19,223
| +140% | +$142K | ﹤0.01% | 4470 |
|
|
2019
Q3 | $62K | Buy |
+13,725
| New | +$62K | ﹤0.01% | 5136 |
|
|
2019
Q1 | – | Sell |
-1,279
| Closed | -$15K | – | 7244 |
|
|
2018
Q4 | $15K | Sell |
1,279
-4,945
| -79% | -$58K | ﹤0.01% | 6081 |
|
|
2018
Q3 | $106K | Buy |
6,224
+3,717
| +148% | +$63.3K | ﹤0.01% | 4692 |
|
|
2018
Q2 | $43K | Buy |
+2,507
| New | +$43K | ﹤0.01% | 5208 |
|